China, India, S. Korea Seen Key Sites For Third Of Sanofi-Aventis Sales
This article was originally published in PharmAsia News
Executive Summary
China and other emerging markets are expected to produce about a third of the income of French drug maker Sanofi-Aventis, the company said
|
China and other emerging markets are expected to produce about a third of the income of French drug maker Sanofi-Aventis, the company said. At the launching of a research and development center in Shanghai, R&D Vice President Marc Cluzel said the Asia Pacific area was expected to amount to a third of the firm's business in just the next few years. The Chinese center is one of several the company plans for the region, with plans for operations in India and South Korea already announced. (Click here for more) "Regional R&D Center Opens" - Shanghai Daily (China) (4/7/10) |